In this analysis, S&P Global Market Intelligence examined U.S. insurance underwriter and insurance broker stocks trading on major exchanges in relation to their mean one-year analyst price targets as of June 1. Only stocks with three or more analyst price targets, and that were trading above $5 per share, were included in this analysis.
Five insurance broker and underwriter stocks could rise upward of 30% over the next 12 months, and an additional four could climb 25%, based on analyst targets.
If Health Insurance Innovations Inc. manages to reach its mean sell-side analyst price target, the company's shares would appreciate by 49.5% over the next 12 months. The stock has already posted a return of 41.3% over the last year; analysts covering the stock across the board recommend buying it at its current levels.
Radian Group Inc. and MGIC Investment Corp. have the second-and third-highest implied upsides among U.S. insurance companies at 40.4% and 36.2%, respectively.
At the other end of the spectrum, insurance underwriter RLI Corp. is trading 16.3% above its mean one-year price target, the most of any insurance stock in this analysis. American Equity Investment Life Holding Co. and W. R. Berkley Corp. were the next two most-overvalued companies, trading at 6.2% and 5.2% above their respective mean price targets.

